TITLE
Prospective biomarker analysis of the randomized CHER-LOB study evaluating the dual anti-HER2 treatment with chemotherapy plus trastuzumab and lapatinib as neoadjuvant therapy for HER2-positive breast cancer

ORGANISM
Homo sapiens

SUMMARY
This SuperSeries is composed of the SubSeries listed below.

DESIGN
Refer to individual Series

PLATFORM
GPL570 [HG-U133_Plus_2] Affymetrix Human Genome U133 Plus 2.0 Array GPL6801 [GenomeWideSNP_6] Affymetrix Genome-Wide Human SNP 6.0 Array

CITATIONS
26245675 , 27484801

